FDA makes premarket exemption official for genetic risk assessments

As of tomorrow, individual genetic risk tests are officially exempt from requiring 501(k) premarket approval, provided the company offering the test has gone through a one-time premarket review of its testing apparatus and at least one test.

from MobiHealthNews https://ift.tt/2sIgLUK